An analysis of the COVID-19 laboratory dataset at AiBST Laboratory in Harare, Zimbabwe, 2020.


Journal

The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926

Informations de publication

Date de publication:
2021
Historique:
received: 24 02 2021
accepted: 06 09 2021
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 27 1 2022
Statut: epublish

Résumé

coronavirus disease 2019 (COVID-19) has become a major public health problem and has spread rapidly around the globe since its first identification in Wuhan, China, in December 2019. Zimbabwe reported its first case on the 20 a retrospective record review of secondary SARS-CoV-2 data from AiBST Laboratory in Harare between May to September 2020 was done. Epi Info TM 7.2.2.6 was used to generate frequencies, proportions and conduct bivariate analysis. a total of 6,535 SARS-CoV-2 laboratory records were analysed. The median age of the patients was 36 years and 55% (3594/6535) were males. There was an increase in average analytical turn-around time (TAT) of SARS-CoV-2 results from May to August 2020. Analytical and preanalytical TAT remained above 2 days from August to September. Males were 1.18 times at risk of being SARS-CoV-2 infected than females (p<0.05). The risk of being SARS-CoV-2 infected increased with age from 1.06 in the 11-20 age group to 1.45 in the 41-50 age group. COVID-19 poses a greater threat to the older age groups and to men. The delayed TAT of SARS-CoV-2 results limits the efforts to control the pandemic. Decentralization of testing to provincial and district level would help improve result TAT.

Identifiants

pubmed: 35059103
doi: 10.11604/pamj.2021.40.183.28520
pii: PAMJ-40-183
pmc: PMC8728806
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

183

Informations de copyright

Copyright: Tendai Chipendo et al.

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Afr J Prim Health Care Fam Med. 2020 Oct 02;12(1):e1-e3
pubmed: 33054266
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Glob Health Res Policy. 2020 Dec 21;5(1):54
pubmed: 33349271
Pan Afr Med J. 2020 Nov 09;37(Suppl 1):33
pubmed: 33456657
Aging Clin Exp Res. 2020 Aug;32(8):1599-1608
pubmed: 32557332
Front Public Health. 2020 Apr 29;8:152
pubmed: 32411652

Auteurs

Tendai Chipendo (T)

Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia.

Takudzwa Marembo (T)

Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia.
Department of Medical Microbiology, Faculty of Medicine, Midlands State University, Gweru, Zimbabwe.

Humphrey Chituri (H)

Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia.

Clayton Munemo (C)

Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia.

Portia Manangazira (P)

Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia.
Epidemiology and Disease Control Directorate, Ministry of Health and Child Care, Harare, Zimbabwe.

Donewell Bangure (D)

Africa Centres for Disease Control and Prevention, African Union Commission, Addis Ababa, Ethiopia.

Justen Manasa (J)

Department of Laboratory Medicine and Investigative Sciences, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
African Institute of Biomedical Science and Technology, Harare, Zimbabwe.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH